After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an international ...

The Volt PFA system. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced today that the FDA approved its Volt pulsed field ablation (PFA) system to treat patients with AFib. Abbott said it plans ...

Despite the earlier movement by competitors in PFA, Abbott CEO Robert Ford told investors in October that the company is “right on time, and we’re complete with the full portfolio.” The company hopes ...

Dermatologists explain the science behind wildly popular treatments like red light therapy, which is now available at home—for a steep price. Full-face LED masks like this one can cost up to several ...

Massive data breach sees millions of credit card details leaked Tom Brady sends clear message to Patrick Mahomes after season-ending injury Judge refuses to grant Sarah Palin a new trial in her libel ...